Human trial reveals mRNA vaccine’s efficacy against lethal brain tumours
In the inaugural human clinical trial involving four adult patients, the vaccine exhibited promising efficacy in combating aggressive and often fatal brain tumours.
In the inaugural human clinical trial involving four adult patients, the vaccine exhibited promising efficacy in combating aggressive and often fatal brain tumours.